trial

Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?

NCTId NCT02805088
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 240 (estimated)
Sponsored by CHU de Reims
Primary completion 2016-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
240 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2014-02
Primary completion
2016-08
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Electroencephalographic recordingsNeuropsychological evaluationclinical evaluation of symptoms

Sponsors

CHU de ReimsLead Sponsor

Sites

1 total
France, France

Facts & assertions

4 sourced
Enrollment
240
Phase
NA
Primary Completion Date
2016-08
Status
UNKNOWN
relationships
The graph out of here
drug
Electroencephalographic recordings
drug
Neuropsychological evaluation
drug
clinical evaluation of symptoms
drug
lead_sponsor
CHU de Reims
company
indication
Schizophrenia
indication
Bipolar Disorder
indication
Bipolar Disorder
indication